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The Autographa californica M nucleopolyhedrovirus (AcMNPV) encodes a gene (open reading frame 32) with homology to vertebrate
and invertebrate fibroblast growth factors (fgfs), key regulators of developmental processes affecting the growth, differentiation, and
migration of many cell types. We studied the temporal regulation of the AcMNPV fgf, vfgf, by Northern (RNA) blot hybridization; vfgf was
transcribed as a 0.6-kb mRNA at early times but as part of a 1.4-kb bicistronic mRNA at late times. The product of vfgf, vFGF, exhibited a
number of characteristics that have also been demonstrated for other FGF homologs. vFGF had strong affinity to heparin, a property
important for FGF signaling via an FGF receptor. vFGF was secreted into the extracellular fluid when expressed in insect cells, suggesting
that it acts as an extracellular ligand. Finally, vFGF was able to stimulate migration of several different types of insect cells. We discuss how
this activity may be important for its function during virus infection.
D 2005 Elsevier Inc. All rights reserved.Keywords: Fibroblast growth factor; Cell motility; Viral pathogenesis; BaculovirusesIntroduction
Fibroblast growth factors (FGFs) are a family of growth
factors widespread in organisms ranging from nematodes to
humans; however, they are not present in unicellular
organisms (Ornitz and Itoh, 2001; Powers et al., 2000). In
general, the structure of FGFs is conserved, and they share a
core region of similarity throughout 140 amino acids in
length, including 28 highly conserved amino acids, of which
a subset interacts with the receptor (Ornitz and Itoh, 2001).
Most, but not all, FGFs encode a terminal signal peptide and
are secreted from cells. FGFs have an array of functions
working as mitogens, motogens, and differentiation factors.
In addition, they have crucial roles in many developmental
processes that include neural cell differentiation, mesoderm
induction, limb formation, osteogenesis, angiogenesis, and
branching morphogenesis during the development of lungs,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.03.013
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E-mail address: lpassar@ksu.edu (A.L. Passarelli).seminiferous tubules, and insect trachea. Inappropriate
expression of some fgfs may lead to the pathogenesis of
cancer. FGFs function by binding heparin or heparan sulfate
proteoglycans to form oligomers, and this complex interacts
specifically with FGF receptors (FGFRs), transmembrane
tyrosine kinases that are activated upon FGF binding,
leading to receptor dimerization and autophosphorylation.
The activated FGFR then stimulates signal transduction
pathways (reviewed in Powers et al., 2000).
The prototype baculovirus, Autographa californica M
nucleopolyhedrovirus (AcMNPV), contains a large DNA
genome of 133,894 base pairs (bp) encoding about 150
genes (Ayers et al., 1994) and infects insects in the order
Lepidoptera. AcMNPV produces two forms of the virus
during its replication cycle with identical genetic makeup
and nucleocapsid structure: budded virus (BV) and occluded
derived virus (ODV). The BV is produced during the late
phase of infection where viral DNA and proteins are
packaged to form nucleocapsids that bud through the
plasma membrane, thus acquiring an envelope (Adams et
al., 1977). The BV spreads systemically within the insect05) 308 – 317
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The ODV is produced during the very late phase of infection
where nucleocapsids remain in the nucleus, are enveloped,
and then are embedded in a matrix that protects the virion in
the environment. When the infected insect dies, it releases
occlusion bodies that another insect ingests (O’Reilly et al.,
1992).
Studies on baculovirus pathology concluded that after
infection of midgut cells, tracheal epithelial cells become
infected, and then BV appears in the hemolymph followed
by the infection of other tissues (Keddie et al., 1989;
Trudeau et al., 2001). The hemolymph may be the main
route of BV distribution in some infected insects (Adams et
al., 1977; Granados and Lawler, 1981). It has been proposed
that the tracheal system of the insect serves as a conduit for
systemic infection as the virus crosses the basal lamina into
the hemocoel of the insect (Engelhard et al., 1994). Other
studies suggest that the BV directly passes through the basal
lamina into the hemolymph where the virus disseminates
(reviewed in Federici, 1997).
Upon infection of insect cell lines with AcMNPV, three
major classes of transcripts, early, late, and very late, are
apparent (O’Reilly et al., 1992). Early transcripts encode
factors necessary for DNA replication and transcription of
late viral genes, as well as auxiliary genes that have roles in
virus–host interactions. After DNA replication, late and
very late genes are transcribed by a viral RNA polymerase
activity (Glocker et al., 1993; Grula et al., 1981; Huh and
Weaver, 1990). Translated late and very late products
include, but are not limited to, structural proteins.
The AcMNPV open reading frame (ORF) 32 has
homology to fibroblast growth factors (FGFs) (Ayers et
al., 1994), and it is conserved in all baculoviruses that have
been sequenced to date that infect insects in the order
Lepidoptera (Garcia-Maruniak et al., 2004; Lauzon et al.,
2004). However, fgf homologs are absent from baculovi-
ruses that infect orders other than Lepidoptera: Culex
nigripalpus NPV that infects insects in the order Diptera
(mosquitoes) (Afonso et al., 2001), and Neodiprion sertifer
NPV and Neodiprion lecontei NPV that infect insects in the
order Hymenoptera (sawflies) (Garcia-Maruniak et al.,
2004; Lauzon et al., 2004). The AcMNPV fgf, vfgf, was
first discovered by sequence homology when the complete
nucleotide sequence of AcMNPV was derived (Ayers et al.,
1994); however, its function during infection is not known.
A study of the BmNPV fgf indicated that it was expressed at
early times post infection (p.i.) using reverse transcriptase-
polymerase chain reaction analysis but the size of the
transcripts or temporal expression in the presence of protein
and DNA replication inhibitors was not presented (Katsuma
et al., 2004). This report also concluded that the BmNPV
FGF was secreted and glycosylated, but its functionality was
not addressed (Katsuma et al., 2004). In this study, we
characterize in detail the temporal expression and transcripts
of vfgf, evaluate biochemical characteristics of its product
that correlate with the function of other known FGFs, andassess its properties for chemoattraction of cells. Based on
these characteristics, we propose a role for vFGF in viral
pathogenesis, but emphasize that other roles are also
possible.Results
Baculovirus fgfs
vfgf is present in all baculoviruses sequenced to date
that infect lepidopterans, but it is absent in the three
baculoviruses that have been completely sequenced to date
that infect other insects. Fig. 1 shows an alignment of the
predicted polypeptide sequence of vfgfs in selected group I
and II NPVs and granuloviruses, and compares them to the
sequence of the Drosophila FGF branchless and a human
FGF, highlighting a conserved signal sequence, and a
heparin binding-growth factor/FGF family domain (Bur-
gess and Maciag, 1989; Thomas, 1988). Potential N-
glycosylation sites in most, but not all, FGFs are indicated.
Northern blot analysis of vfgf transcripts
We determined the temporal regulation and overall size
of vfgf mRNAs by Northern blot analysis. Inspection of
sequences upstream of the vfgf ORF revealed the presence
of a TATA box 29 bp upstream of the translational start
codon. We infected cells with AcMNPV at a multiplicity of
infection of 20 PFU per cell, purified total RNA at different
times p.i., and performed Northern blot analysis using an
RNA-specific probe derived from the vfgf ORF as described
in Materials and methods (Fig. 2A).
A 0.6-kb transcript was first observed at 3 h p.i. and
remained until 12 h p.i. when a probe complementary to the
vfgf ORF was utilized (Fig. 2B). At 24 and 48 h p.i.,
transcription slightly decreased. Transcription was also
observed in the presence of cycloheximide, a protein
synthesis inhibitor, indicating that prior protein synthesis
was not required for vfgf transcription. This is indicative of
early genes, where synthesis is dependent on host proteins
and/or viral proteins carried in the virus particle but not on
viral gene products that need to be synthesized after virus
infection. Similarly, vfgf was transcribed in the presence of
aphidicolin, a DNA synthesis inhibitor. Late and very late
viral genes require viral DNA replication for expression.
Thus, since vfgf is transcribed at early times p.i., and in the
presence of cycloheximide and aphidicolin, it can be
designated an early gene. The early 0.6-kb RNA agrees
with the predicted size for an RNA corresponding to the
546-nt vfgf ORF, given that the putative transcriptional start
site and polyadenylation signals are fairly close the
beginning and end of the ORF, respectively.
In addition, two prominent larger late RNAs of 1.4 and 3.1
kb were observed starting at 9–12 h p.i. (Fig. 2B). These late
transcripts also hybridized to a probe complementary to ORF
Fig. 1. Alignment of baculovirus FGFs, Drosophila FGF branchless (Bnl), and a human FGF. In the sequences shown, dark grey shading denotes identical
residues, light grey shading shows similarities among proteins, bold-type residues highlight the putative heparin-binding growth factor/FGF family domain,
italicized residues indicate putative cleavable signal sequence, underlined residues show putative N-glycosylation sites, numbers in parenthesis refer to amino
acids of the corresponding polypeptide, and double slashes indicate the predicted cleavage sites. GenBank database accession numbers for the sequences shown
are as follows: A. californica MNPV (AcMNPV) FGF (NC 001623), B. mori NPV (BmNPV) FGF (NC 001962), Choristoneura fumiferana MNPV (CfMNPV)
FGF (NC 004778), Orgyia pseudotsugata MNPV (OpMNPV) FGF (NC 001875), Lymantria dispar NPV (LdNPV) FGF (NC 001973), Xestia c-nigrum GV
(XecnGV) FGF (NC 2331), Plutella xylostella GV (PxGV) FGF (NC 002593), human FGF 16 (NM 003868), and Drosophila FGF Bnl (NM 169875).
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were not transcribed either in the presence of cycloheximide
or aphidicolin. Interestingly, vfgf may be transcribed at late
times as part of a 1.4-kb bicistronic mRNA, since this mRNA
hybridized to probes complementary to ORFs 32 and 33. The
gene upstream of and in the same direction of vfgf, orf 33 (550
nt in length), does not appear to contain a polyadenylation
signal at its 3V end and its transcripts may coterminate with the
vfgf early mRNA using the polyadenylation signal down-
stream the vfgf ORF (17 nt downstream of the translational
stop codon for vfgf). We do not know the identity of the larger
3.1-kb RNA and did not pursue it any further in this study.Less abundant late mRNAs were also apparent (Figs. 2B and
C, lanes 24). The first late transcriptional start sites upstream
of the vfgf ORF are present 202 and 15 nt upstream of the
translational start codons of vfgf and ORF 33, respectively.
Whether these mRNAs utilize either of these late transcrip-
tional start sites was not investigated. We also performed
primer extension analysis and observed two early primer
extension products that terminated 12 and 13 nt upstream of
the translational ATG codon of the vfgf ORF (results not
shown). A short leader sequence starting at 10 nt upstream of
the translational start codon was also observed in the BmNPV
fgf (Katsuma et al., 2004).
Fig. 2. Northern blot analysis of vfgf transcripts. (A) A schematic shows vfgf and adjacent open reading frames and the homologous region 2 (hr2) where the
thick filled arrows indicate the direction of transcription. The transcripts that traverse the region (thin arrows) and their temporal expression (E, early; L, late)
are shown above the open reading frames. The sizes of the transcripts in panels B and C below are indicated in parentheses and to the right of the thin arrows.
The dotted arrow indicates that the 5V and 3V ends of the transcript were not defined. The asterisk (*) indicates the approximate location of a polyadenylation
signal. Thin arrows below the open reading frames labeled ‘‘probe 1’’ and ‘‘probe 2’’ indicate RNA probes used in Northern blots in panels B and C,
respectively. (B and C) Total RNA was extracted from SF-21 cells either mock-infected (mi) or infected with AcMNPV at the time indicated at the top in
hours. RNA was extracted from cells treated with cycloheximide (12C) or aphidicolin (12A) at 12 h p.i. The size and position of predominant transcripts are
indicated. M, molecular weight markers.
Fig. 3. Secretion of vFGF. SF-21 cells were transfected with either
pHSFGFHA (lanes 1 and 2) or a plasmid expressing HA-tagged P47,
pHSEpiHisp47, (lanes 3 and 4). Extracellular proteins present in the
supernatant (sup; lanes 2 and 4) or intracellular proteins in the cell lysate
(cell; lanes 1 and 3) were resolved by SDS–PAGE, proteins were
transferred to a PVDF membrane, and reacted with anti-HA antibody.
The migration of vFGF and P47 is indicated by arrows to the right. The
asterisk (*) indicates a non-specific immunoreactive band in the
supernatant.
C. Detvisitsakun et al. / Virology 336 (2005) 308–317 311vFGF production and secretion
We constructed a plasmid, pHSFGFHA, using the
Drosophila heat shock protein 70 (hsp70) promoter to
express vfgf with an in-frame C-terminal influenza hemag-
glutinin (HA) epitope tag. SF-21 cells were transfected with
pHSFGFHA and protein lysates from either the cell pellet or
the culture supernatant were resolved by SDS–PAGE and
immunoblotted with anti-HA monoclonal antibody. We
found that a protein of about 20 kDa, in agreement with
the predicted size for vFGF, was expressed from this
plasmid. vFGF was found in the cell lysate but was also
secreted into the culture medium (Fig. 3, lanes 1 and 2),
consistent with its N-terminal predicted signal sequence.
vFGF in the cell lysate may potentially contain vFGF bound
to the extracellular matrix. A plasmid containing a viral
RNA polymerase subunit (P47) tagged with HA that was
not expected to be secreted was used as a control to monitor
any contamination in the pellet and supernatant fractions
(Fig. 3, lanes 3 and 4). The fgf from Bombyx mori NPV has
also been shown to be secreted (Katsuma et al., 2004).
vFGF affinity to heparin
FGFs bind heparan sulfate proteoglycans in the
extracellular matrix, and upon cleavage, complexes of
heparin-bound FGFs bind and activate FGFRs. Previously
characterized FGFs bind heparin-Sepharose and elute athigh salt concentrations between 1.0 and 2.0 M NaCl
(reviewed in Powers et al., 2000). To test whether vFGF
had high affinity to heparin like other characterized FGFs,
the supernatant was collected from SF-21 cells previously
transfected with pHSFGFHA, applied to heparin-Sephar-
ose, and bound proteins were eluted with increasing
concentrations of NaCl. vFGF routinely started to elute
between 1.0 and 1.2 M NaCl (Fig. 4A), indicating that
vFGF conserved the property of binding heparin strongly
that is critical for the function of other FGFs.
Fig. 4. vFGF binds heparin. SF-21 cells were transfected with either pHSFGFHA (A) or pHSEpiOpIAP (B). Proteins in the extracellular fluid (A) or in the cell
lysate (B) were collected and incubated with heparin-Sepharose beads. The heparin-bound proteins were washed with phosphate buffer containing different
concentrations of NaCl as indicated above each lane. Fractions were collected and detected by immunoblotting with monoclonal anti-HA. Migration of vFGF
and OpIAP is indicated to the right of each panel. SM, starting material; FT, flow through.
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HA-tagged OpIAP, a baculovirus inhibitor of apoptosis
(Birnbaum et al., 1994), a protein that we did not expect to
have high affinity for heparin, eluted from heparin primarily
in the flow through when a cell lysate was allowed to bind
heparin-Sepharose (Fig. 4B).
Chemoattraction properties of vFGF for different cell types
One characteristic of FGFs is their ability to induce cell
motility. We tested the ability of vFGF for chemoattractionFig. 5. Chemotactic activity of vFGF. (A) Different concentrations of heparin-purif
using TN-368 cells in three independent assays. The relative CellTiter-Glo units of
of 1.0) are presented on the ordinate axis. The numbers on the abscissa indicate
concentration of vFGF (2 Al) was used to perform transmigration experiments with
SF-21 and T. ni hemocytes to determine the optimal concentration required for thes
in the upper chamber of a transwell and allowed to migrate to vFGF. vFGF and co
(vFGF) or pBluescript control (ctrl), respectively, and proteins in the extracellula
heparin-purified vFGF, as determined by titration of vFGF in transmigration assa
measurement of viable cells that had migrated to the lower compartment was ob
standard error of at least three independent experiments.of SF-21, TN-368, and hemocytes isolated from last instar
Trichoplusia ni (Fig. 5). pHSFGFHA or pBluescript was
transfected into SF-21 cells and the supernatant containing
vFGF or proteins present in the supernatant of vector-
transfected cells was partially purified by heparin-Sepharose
and used in cell migration assays. Expression of vfgf before
and after heparin purification was monitored by immuno-
blotting using anti-HA antibody (data not shown).
Since vFGF was not purified to homogeneity, we could
not add a specific and known amount of vFGF in all
experiments. Thus, we generated a dose-response curve foried vFGF or control proteins were tested for their ability to enhance motility
cells treated with vFGF compared to control-treated cells (assigned a value
the volume (Al) of heparin-purified and eluted proteins used. The optimal
TN-368 cells (C) below. Similar titration experiments were performed with
e cells. SF-21 (B), TN-368 (C), or last instar T. ni hemocytes (D) were plated
ntrol proteins were obtained from SF-21 cells transfected with pHSFGFHA
r fluid were partially purified by heparin-Sepharose. An optimal amount of
ys, was added to the lower compartment of the transwell. After 3.5–4 h, a
tained by CellTiter-Glo. The bars above each column indicate the mean T
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purified vFGF and used the optimal concentration of vFGF
in transmigration assays. An example is presented in Fig.
5A. vFGF was not able to induce transmigration of insect
cells when low concentrations of the protein (e.g., 0.2–
1.0 Al, Fig. 5A) were assayed. Optimal concentrations were
reached with 2.0 Al of vFGF, and addition of higher
concentrations of vFGF (e.g., 10–20 Al, Fig. 5A, and
results not shown) reduced activity, probably due to
diffusion of vFGF, preventing the ability of a gradient of
FGFs to be established.
We observed that vFGF was able to stimulate trans-
migration of cells derived from the ovarian cell-derived
Lepidoptera cell lines permissive for AcMNPV infection,
SF-21 and TN-368 cells, 2.3- and 1.8-fold, respectively,
compared to transmigration of these cells to proteins
purified from cells transfected with pBluescript (Figs. 5B
and C). Similar results have been reported for other better
characterized FGFs (Lee et al., 2003; Ritch et al., 2003).
Interestingly, vFGF was able to stimulate migration of
hemocytes obtained from last instar T. ni larvae, consistent
with the possibility that vFGF is able to attract hemocytes in
the infected host (Fig. 5D). In addition, this vFGF-
stimulated cell motility was verified by microscopic
examination of cells in the lower transwell compartment
(results not shown). In these experiments, the migration
observed in the controls may be due in part to secreted
cellular FGFs that were purified and to which target cells in
the apical transwell insert may be responding.Discussion
Most FGFs are secreted from cells where they act
extracellularly. In addition, they have a high affinity to
heparin. Finally, among their properties is their ability to
function as chemoattractants. These three properties are
conserved in the AcMNPV fgf in cell culture, since it has a
functional signal peptide that allows secretion of the
polypeptide (Fig. 3), it binds heparin (Fig. 4), and enhances
cell migration (Fig. 5).
A few examples exist of viruses that encode growth
factors other than fgfs or viruses that affect host fgfs.
However, to our knowledge, the baculovirus fgfs are the
only fgfs encoded by viruses. The vaccinia virus growth
factor, VGF, has homology to epidermal growth factors
(Bloomquist et al., 1984; Brown et al., 1985; Reisner, 1985)
and is a virulence factor that stimulates cell growth (Buller
et al., 1988). Another well-described example is the viral
vascular endothelial growth factor, vVEGF, encoded by
parapoxviruses (Lyttle et al., 1994; Ueda et al., 2003), that is
involved in angiogenesis (Savory et al., 2000). In mice,
retroviruses use either WNT or FGF as integration hot spots,
activating the genes, and leading to carcinogenesis (Katoh,
2002). Respiratory syncytial virus (RSV) enhances the
production of basic FGF, and this may lead to fibroblastactivation involved in remodeling the airway epithelium due
to chronic inflammatory changes associated with asthma
(Dosanjh et al., 2003). Upregulation of basic FGF was
suggested to explain prolonged wheezing after RSV
infection (Dosanjh et al., 2003). More recently, Raf-induced
VEGF augmented Kaposi’s sarcoma-associated herpesvirus
infection of cells (Hamden et al., 2004).
Branching epithelial morphogenesis is central in verte-
brate development of lungs, vasculature, kidneys, and most
glands, involving cell migration, division, and attracting
more cells to form complex structures apparent in mature
organs. In insects, tracheal morphogenesis leads to a
network of epithelial tubules that deliver oxygen to every
tissue, and Drosophila has served as a model system to
study the morphological, genetic, and molecular aspects of
this process. The Drosophila FGF gene, branchless, is
responsible for controlling tracheal cell migration and the
pattern of branching (Sutherland et al., 1996). Its receptor,
breathless, is expressed on the surface of developing
tracheal cells (Glazer and Shilo, 1991; Klambt et al.,
1992). Localized activation of the receptor guides the
migration of tracheal cells forming primary and secondary
branches aided by a number of factors (reviewed in
Ghabrial et al., 2003). Terminal branching is regulated by
oxygen requirements in cells signaled by branchless
(Jarecki et al., 1999). Thus, branchless is an essential
mitogen and chemoattractant in the development of the
embryonic, larval, and differentiated adult tracheal system
(Sato and Kornberg, 2002; Sutherland et al., 1996). The
AcMNPV FGF is 42% identical to the FGF core sequences
of branchless (amino acids 220–409 of branchless). These
core sequences encode structural components composed of
12 antiparallel h-strands, heparin-, and receptor-binding
regions.
Twenty-six baculovirus genomes are available to date
and 23 encode vfgf. The viruses encoding vfgf infect
Lepidoptera (moths), initiating infection in the midgut of
the insect larvae. Infection then spreads systemically until
the insect dies. Some granuloviruses encode more than one
copy of vfgf (accession number NC004062; Hashimoto et
al., 2000; Wormleaton et al., 2003). The advantage for more
than one copy of vfgf with respect to pathogenesis or
whether both copies are functional is not known. Further-
more, it would be interesting to find out if the diverse tissue
tropisms exhibited by granuloviruses, ranging from midgut
restrictions to virus distribution in several tissues (Federici,
1997), are related to vfgf function. The baculoviruses that do
not encode fgf have a smaller genome and are phylogeneti-
cally considered to be more ancient and divergent from
those that infect Lepidoptera (Garcia-Maruniak et al., 2004;
Lauzon et al., 2004). These divergent viruses infect the
Culex mosquito (Diptera) and Neodiprion sawflies (Hyme-
noptera). More interestingly, these baculoviruses only
replicate at the primary site of infection, the epithelial cells
of the midgut, and do not spread systemically (Federici,
1997; Moser et al., 2001). It is possible that vfgf is required
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systemically. Thus, baculoviruses infecting Lepidoptera
may have acquired the fgf homologs in order to efficiently
invade and replicate in additional tissues.
Given the biological and biochemical characteristics of
vFGF presented in this study, possible functions for vfgf in
viral pathogenesis can be proposed, although alternative
functions at other stages of the viral replication cycle are
also possible. vFGF may attract uninfected hemocytes to
trachea or other infected tissues by chemotaxis, allowing the
virus to infect these cells and be spread through the open
circulatory system of the insect. Hemocytes are motile cells
that migrate towards wound sites or invading organisms for
encapsulation. One possibility is that vFGF is used as a lure
in which hemocytes are signaled by vFGF in a similar
manner to that of chemokine signals that are sent by
vertebrate cells upon virus infection to attract immune cells
to sites of infection. vFGF may also induce cell proliferation
of hemocytes or other cell types, thus augmenting its
replication capacity by increasing the number of progeny
virus. Cell proliferation was observed in response to the
vaccinia virus virulence factor, VGF, yielding increased
numbers of infectious progeny (Buller et al., 1988).
Alternatively, vFGF may be serving as a signal for
branching and migration of tracheal cells that allow virus
accessibility to uninfected tissues.
This study presents the initial functional characterization
of the AcMNPV fgf and its implications in virus spread by
modulating the host signal transduction pathways. We are in
the process of characterizing a vfgf knockout virus in vitro
and in vivo to discriminate among its possible roles during
virus pathogenesis. Its function as a virulence factor may be
useful in augmenting the applications of recombinant
baculoviruses used for pest control, including baculoviruses
that infect mosquitoes.Materials and methods
Cells and virus
TN-368 cells (Hink, 1970) derived from the cabbage
looper T. ni and IPLB-SF-21 cells (SF-21) derived from the
fall armyworm Spodoptera frugiperda (Vaughn et al., 1977)
were cultured at 27 -C in TC-100 medium (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen) and
0.26% tryptose broth as described previously (O’Reilly et
al., 1992). The AcMNPV L1 strain (Lee and Miller, 1978)
was propagated and tittered in SF-21 cells, and used to
infect cells at a multiplicity of infection of 20 plaque-
forming units (PFU) per cell (O’Reilly et al., 1992).
Plasmid construction
The plasmid pHSFGFHA contained the vfgf ORF under
control of theDrosophila hsp70 promoter, the HA epitope tagat the C terminus of FGF, and a polyadenylation signal
derived from theOrgyia pseudotsugata inhibitor of apoptosis
gene (Opiap) (Crouch and Passarelli, 2002). First, the vfgf
ORF was amplified by PCR using a plasmid containing viral
genomic DNA in this region. The amplified product
expanded from the translational start ATG codon to the last
codon excluding the translational stop codon and included an
XhoI at the 5V end and a NotI site at the 3V end to facilitate
cloning. Next, the amplified product was cloned into pBlue-
script at the XhoI andNotI sites to generate pBSFGF. The HA
tag and a translational stop codon were introduced at the C
terminus of FGF by annealing two complementary primers
(5V -GGCCGCCTACCCATACGACGTCCCAGATTA-
CGCCTAACCGC-3V and its complement) containing NotI
and SacII sites at the ends and cloned into the NotI and SacII
sites of pBSFGF. The resulting plasmid containing a C-
terminally tagged vfgf, pBSFGFHA, was cut with XhoI and
SacI to obtain a fragment with the HA-tagged vfgf. Finally,
the ends were repaired with T4 DNA polymerase and cloned
into the Klenow-repaired Bsu 36I sites of pHSGFP (Crouch
and Passarelli, 2002) to replace the green fluorescent gene for
the HA-tagged FGF, and the resulting plasmid was named
pHSFGFHA. The sequence of the vfgf insert in pHSFGFHA
was verified by nucleotide sequencing.
The plasmids pHSEpiOpIAP and pHSEpiHisp47 have
been previously described (Vucic et al., 1997). Briefly, the
plasmid pHSEpiOpIAP contains the Op-iap3 gene with an
N-terminal HA epitope tag driven by the Drosophila hsp70
promoter. pHSEpiHisp47 contains the AcMNPV p47 gene
with N-terminal HA and poly-histidine tags under control of
the hsp70 promoter.
Transfection of cells
In experiments in which vFGF was detected in the cell
lysate or supernatant of transfected cells, 2 Ag of either
pHSFGFHA or pHSEpiHisp47 was introduced into 0.5 
106 SF-21 cells plated on 35-mm cell culture dishes by
using 3 Al of a liposome preparation as previously described
(Crouch and Passarelli, 2002). Cells were maintained for 4 h
at 27 -C in the liposome-DNA mix. This mix was then
replaced with TC-100 media containing 10% fetal bovine
serum and incubated at 27 -C. Twenty-four hours after
addition of DNA, cells were incubated at 42 -C for 30 min
to induce expression of genes from the hsp70 promoter.
Cells were allowed to express proteins for 4 h at 27 -C
before cells and supernatant were harvested. In heparin
purification experiments, 6 Ag of either pHSFGFHA or
pBluescript II SK(+) (Stratagene) was transfected into 3.0 
106 SF-21 cells as described above, but proteins were
collected 36 h post-transfection.
Insect rearing and hemocyte collection
T. ni eggs were obtained from Entopath Inc. (Easton,
PA). Individual first instar caterpillars were transferred to 1-
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Inc.) and reared at 27 -C with a 12-h light/dark cycle.
Caterpillars were allowed to grow to the last instar.
Last instar caterpillars were chilled at 4 -C for 30 min
before hemolymph extraction. Hemolymph was collected
by cutting an anal proleg and allowing the caterpillar to
bleed onto a piece of parafilm. Hemolymph was transferred
to ice-cold anti-coagulant buffer (4 mM NaCl, 40 mM KCl,
1.7 mM piperazine-N,N’-bis(2-ethanesulfonic acid) (PIPES),
146 mM sucrose, 0.1% polyvinylpyrolidone, 8 mM EDTA,
9.5 mM citric acid, and 27 mM sodium citrate) at 1:1 vol/vol
ratio and centrifuged at 300  g at 4 -C. Unseparated
hemocyte cells were washed twice with ice-cold anti-
coagulant buffer and then resuspended in the same buffer.
Hemocytes were counted using a hemocytometer and 2–3
104 cells were used in transmigration assays.
RNA isolation
SF-21 monolayers (2  106 cells per 60-mm diameter
dish) were infected with AcMNPV at a multiplicity of
infection of 20 PFU per cell. The virus was allowed to
adsorb for 1 h at room temperature, and time zero was
defined as the time when the virus was removed and
incubation at 27 -C commenced. The protein synthesis
inhibitor cycloheximide was added to the cells at 100 Ag/ml
for 30 min before infection and maintained thereafter. The
DNA synthesis inhibitor aphidicolin was added at 5 Ag/ml
following virus adsorption. Total RNA was isolated at
selected hours p.i. with Trizol reagent (Invitrogen).
Northern blot analysis
Samples of total RNA (20 Ag per lane) were electro-
phoresed on a formaldehyde–1% agarose gel, transferred to
a nylon membrane, and hybridized to a-32P-radiolabeled
riboprobes. Two probes were generated by first PCR-
amplifying vfgf from the translational start codon to the
translational stop codon and ORF 33 from 27,727 to 28,284
nt of AcMNPV (Ayers et al., 1994) (from 6 nt downstream
of the translational stop codon to 3 nt upstream of the
translational start codon). PCR products were cloned by
using the TA Cloning kit (Invitrogen) and the cRNA probes
were synthesized by in vitro transcription using T7 RNA
polymerase in the presence of a-32P[UTP].
Immunoblotting
Cell culture supernatant from transfected cells was
collected and spun down at 1000  g for 5 min to
remove residual cells, and proteins in the supernatant
were mixed with sodium dodecyl sulfate (SDS)-Laemmli
buffer. Attached cells were washed twice with phosphate-
buffered saline (PBS), pH 6.2 (Potter and Miller, 1980),
and collected with SDS-Laemmli buffer. Proteins from
cells and supernatant were resolved by SDS–15%polyacrylamide gel electrophoresis (PAGE), transferred
to a PVDF membrane (Pierce), and immunodetected with
1:1000 dilution of HA.11 monoclonal antibody (Cova-
nce), 1:3000 dilution of goat anti-mouse IgG-horseradish
peroxidase (Bio-Rad), and SuperSignal chemiluminescent
substrate (Pierce).
Purification of vFGF through heparin-Sepharose
Supernatant from cells transfected with pHSFGFHA or
pBluescript was harvested and spun down at 1000  g at
4 -C to remove residual cells. Proteins in the supernatant
of transfected cells were then incubated with heparin-
Sepharose 6 Fast Flow beads (Amersham Biosciences)
previously washed with excess deionized water three times
for 4 h at 4 -C and constant rotation. Subsequently, the
mixture was loaded onto a 2-ml column (BD Bioscience
Clontech) and washed with phosphate buffer (10 mM
NaH2PO4) containing different concentrations of NaCl
from 0.15 to 2.0 M as indicated. Each fraction was collected
and proteins were detected by immunoblotting. Proteins
eluted with phosphate buffer containing 30% glycerol and
1.4 M NaCl and were used in transmigration assays.
Transmigration assays
Cell migration was assessed using Costar transwells
with polycarbonate membrane inserts. For migration of
SF-21 and TN-368 cells, approximately 3–5  104 cells
were loaded onto 8 AM pore-size transwell inserts.
Different amounts of heparin-purified vFGF or control
proteins (pBluescript-transfected cells) as indicated were
added to 24-well plates containing 600 Al of PBS, pH 6.2,
or TC-100 lacking serum. For hemocyte migration,
approximately 2–3  104 cells were loaded onto 3 AM
pore-size transwell inserts and different amounts of
heparin-purified vFGF or control proteins were added to
24-well plates in which each well contained 600 Al of
anti-coagulant buffer. The transwell inserts were then
transferred to the 24-well plates containing heparin-
purified proteins. After 3.5- to 4-h incubation at 27 -C,
transwell inserts were removed and cells that migrated were
quantified using CellTiter-Glo luminescent substrate to
measure ATP present according to the protocol provided
by the manufacturer (Promega) and viable cells determined
with the Wallac Victor3 1420 Multilabel counter (Perkin-
Elmer). ATP luminescence-based motility assays are con-
sidered more reliable and sensitive than other methods used
to enumerate cells (de la Monte et al., 2002). All experiments
were performed independently at least three times.Acknowledgments
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